FI960504L - Menetelmä terapeuttisten yhdisteiden ja rasvahappojen muodostamien konjugaattien valmistamiseksi - Google Patents

Menetelmä terapeuttisten yhdisteiden ja rasvahappojen muodostamien konjugaattien valmistamiseksi Download PDF

Info

Publication number
FI960504L
FI960504L FI960504A FI960504A FI960504L FI 960504 L FI960504 L FI 960504L FI 960504 A FI960504 A FI 960504A FI 960504 A FI960504 A FI 960504A FI 960504 L FI960504 L FI 960504L
Authority
FI
Finland
Prior art keywords
fatty acids
therapeutic compounds
preparing conjugates
conjugates
preparing
Prior art date
Application number
FI960504A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960504A7 (fi
FI960504A0 (fi
Inventor
Robert George Whittaker
Veronika Judith Bender
Wayne Gerrard Reilly
Original Assignee
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org
Publication of FI960504L publication Critical patent/FI960504L/fi
Publication of FI960504A7 publication Critical patent/FI960504A7/fi
Publication of FI960504A0 publication Critical patent/FI960504A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI960504A 1993-08-02 1994-08-02 Menetelmä terapeuttisten yhdisteiden ja rasvahappojen muodostamien konjugaattien valmistamiseksi FI960504A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM032593 1993-08-02
PCT/AU1994/000440 WO1995004030A1 (en) 1993-08-02 1994-08-02 Therapeutic compound - fatty acid conjugates

Publications (3)

Publication Number Publication Date
FI960504L true FI960504L (fi) 1996-02-02
FI960504A7 FI960504A7 (fi) 1996-02-02
FI960504A0 FI960504A0 (fi) 1996-02-02

Family

ID=3777106

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960504A FI960504A0 (fi) 1993-08-02 1994-08-02 Menetelmä terapeuttisten yhdisteiden ja rasvahappojen muodostamien konjugaattien valmistamiseksi

Country Status (14)

Country Link
US (2) US5792786A (de)
EP (1) EP0712389B1 (de)
JP (1) JPH09501655A (de)
CN (1) CN1125040C (de)
AT (1) ATE198880T1 (de)
CA (1) CA2167818A1 (de)
DE (1) DE69426629T2 (de)
DK (1) DK0712389T3 (de)
ES (1) ES2156156T3 (de)
FI (1) FI960504A0 (de)
NO (1) NO313227B1 (de)
NZ (1) NZ269773A (de)
RU (1) RU2137755C1 (de)
WO (1) WO1995004030A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM747694A0 (en) * 1994-08-16 1994-09-08 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids and peptides
US5952499A (en) * 1995-01-16 1999-09-14 Commonwealth Scientific And Industrial Research Organisation Therapeutic compound-fatty acid conjugates
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
US6015821A (en) * 1995-05-01 2000-01-18 Horrobin; David Frederick Nicotinic acid esters and pharmaceutical compositions containing them
AUPN741696A0 (en) * 1996-01-05 1996-01-25 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids ii
DE19631189A1 (de) * 1996-08-02 1998-02-05 Max Delbrueck Centrum Neuartige kationische Amphiphile für den liposomalen Gentransfer
AUPP751398A0 (en) * 1998-12-04 1999-01-07 Commonwealth Scientific And Industrial Research Organisation Methotrexate derivatives
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
US6716452B1 (en) * 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
KR20040014544A (ko) * 2001-06-05 2004-02-14 컨트롤 딜리버리 시스템즈 인코포레이티드 서방 진통제 화합물
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US20030148379A1 (en) * 2002-02-06 2003-08-07 Roitman Daniel B. Methods for making microbar encoders for bioprobes
ZA200502613B (en) * 2002-10-10 2006-10-25 Yeda Res & Dev Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
MXPA05012850A (es) * 2003-05-29 2006-05-17 New River Pharmaceuticals Inc Compuestos de anfetamina resistentes al abuso.
EP1744747A4 (de) 2004-04-26 2009-12-02 Univ Vanderbilt Indolessigsäure und indolessigsäurederivate als therapeutische wirkstoffe mit verminderter gastrointestinaler toxizität
EP2111881A1 (de) 2004-07-05 2009-10-28 Ziscoat N.V. biokompatible Beschichtungen für medizinische vorrichtungen mit Molekularsieben
US7691364B2 (en) * 2005-01-28 2010-04-06 Bezwada Biomedical, Llc Functionalized drugs and polymers derived therefrom
PL1864668T3 (pl) * 2006-06-01 2013-04-30 Santen Sas Wykorzystanie proleku do okulistycznego podawania śródszklistkowego
US7736624B2 (en) 2006-06-19 2010-06-15 Univ Vanderbilt Methods and compositions for diagnostic and therapeutic targeting of COX-2
WO2008012605A1 (en) * 2006-07-27 2008-01-31 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of ketoprofen and related compounds with very fast skin penetration rate
EP2315740B1 (de) 2008-07-08 2017-10-25 Catabasis Pharmaceuticals, Inc. Fettsäureacetylierte salicylate und deren verwendungen
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
WO2013059245A1 (en) 2011-10-17 2013-04-25 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
MY190370A (en) * 2012-06-26 2022-04-18 Polyactiva Pty Ltd Polymer-nsaid conjugate
CR20170338A (es) * 2015-01-23 2017-09-12 Novartis Ag Conjugados de ácidos grasos y apelina sintética con mayor vida media
EP4559896A4 (de) * 2022-07-19 2025-10-22 Univ Hokkaido Nat Univ Corp Ph-sensitive kationische lipid- und lipidnanopartikel
CN116496193B (zh) * 2023-03-10 2026-01-02 圣诺生物医药技术(苏州)有限公司 一种氨基酸脂质形成的纳米递送系统及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3686238A (en) * 1970-01-19 1972-08-22 Syntex Corp Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
BE871709A (fr) * 1978-10-31 1979-02-15 Abbott Lab Procede de preparation de composes doues d'une activite anti-inflammatoire
DE3904119A1 (de) 1989-02-11 1990-08-16 Hoechst Ag Polymerfixiertes methotrexat, verfahren zur herstellung und verwendung
EP0506748B1 (de) * 1989-12-22 1995-12-13 Commonwealth Scientific And Industrial Research Organisation An fette gebundene aminosäuren, peptide oder deren derivate
CA2106483A1 (en) 1991-03-19 1992-09-20 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
ATE191147T1 (de) * 1991-07-26 2000-04-15 Commw Scient Ind Res Org System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
DE4311987A1 (de) 1993-04-07 1994-10-13 Schering Ag Neue Glucocorticoide

Also Published As

Publication number Publication date
DE69426629D1 (de) 2001-03-01
DE69426629T2 (de) 2001-08-02
ATE198880T1 (de) 2001-02-15
NO960389L (no) 1996-01-30
CN1128531A (zh) 1996-08-07
ES2156156T3 (es) 2001-06-16
NZ269773A (en) 1997-11-24
NO960389D0 (no) 1996-01-30
EP0712389A1 (de) 1996-05-22
JPH09501655A (ja) 1997-02-18
NO313227B1 (no) 2002-09-02
FI960504A7 (fi) 1996-02-02
EP0712389A4 (de) 1997-04-09
CA2167818A1 (en) 1995-02-09
DK0712389T3 (da) 2001-06-05
US5792786A (en) 1998-08-11
US6353124B1 (en) 2002-03-05
EP0712389B1 (de) 2001-01-24
WO1995004030A1 (en) 1995-02-09
CN1125040C (zh) 2003-10-22
RU2137755C1 (ru) 1999-09-20
FI960504A0 (fi) 1996-02-02

Similar Documents

Publication Publication Date Title
FI960504L (fi) Menetelmä terapeuttisten yhdisteiden ja rasvahappojen muodostamien konjugaattien valmistamiseksi
NO973283D0 (no) Konjugater mellom terapeutiske forbindelser og fettsyrer
FI955180A7 (fi) Naftaleenifosfonihappojen ureidojohdannaiset ja menetelmä niiden valmi stamiseksi
FI944164A0 (fi) Etikkahapon valmistusmenetelmä
FI951305L (fi) Lääketieteellinen materiaali ja menetelmä sen valmistamiseksi
FI944275L (fi) Menetelmä syklisten estereiden valmistamiseksi hydroksihapoista ja niiden johdannaisista
FI951593L (fi) Uusi menetelmä bakkatiini-III:n ja 10-desasetyylibakkatiini-III:n esteröimiseksi
FI940874A0 (fi) Menetelmä maitohapon ja maitohappoestereiden valmistamiseksi
FI953919A7 (fi) Pyrrolydeenimetyylijohdannaiset ja menetelmä niiden valmistamiseksi
FI944713L (fi) 4-difenyylimetyylipiperidiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI891123A7 (fi) Menetelmä 1-syklopropyylikinolonikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
NO930525D0 (no) Framgangsmaate for utvikling av umettede fettsyrer
FI955708L (fi) Menetelmä 2-fenyyli-3-aminopiperidiinin valmistamiseksi ja erottamiseksi
FI932028A7 (fi) Menetelmä uusien N-aralkyyli- ja N-heteroaralkyyliaminoalkaanifosfiinihappojen valmistamiseksi
NO172980C (no) Fremgangsmaate for dehalogenering av alfa-halogenerte karboksylsyrer og anvendelse av fremgangsmaaten
FI925243A7 (fi) Analogiamenetelmä uusien aminoalkaanifosfiinihappojen ja niiden suolojen valmistamiseksi
DE69507006D1 (de) Ceramid-3-derivate von einfachungesättigten fettsäuren
FI933676A7 (fi) Menetelmä happojen ja emästen tuottamiseksi
FI933432A7 (fi) Kviinihapon johdokset ja menetelmä niiden valmistamiseksi
FI942581A0 (fi) Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi
FI972464A0 (fi) Diaminoeetterin diklavulanaattisuola ja menetelmä sen valmistamiseksi
PL317043A1 (en) Method of and intermediate products for obtaining salts of naphtyridinocarboxylic acids
FI943997A7 (fi) Menetelmä aromaattisten metoksikarboksyylihappojen metyyliestereiden valmistamiseksi
FI930383A7 (fi) Menetelmä ja välituote 2-hydroksi-3-sulfido-3-fenyylipropaanihappojen valmistamiseksi
FI901180A7 (fi) Menetelmä bentsyylipalorypälehappojen ja niiden estereiden valmistamiseksi

Legal Events

Date Code Title Description
MA Patent expired